Free Trial
NASDAQ:MNOV

MediciNova (MNOV) Stock Price, News & Analysis

MediciNova logo
$1.25 0.00 (0.00%)
As of 04:00 PM Eastern

About MediciNova Stock (NASDAQ:MNOV)

Key Stats

Today's Range
$1.25
$1.29
50-Day Range
$1.25
$1.59
52-Week Range
$1.12
$2.55
Volume
34,208 shs
Average Volume
36,426 shs
Market Capitalization
$61.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Strong Buy

Company Overview

MediciNova Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

MNOV MarketRank™: 

MediciNova scored higher than 37% of companies evaluated by MarketBeat, and ranked 690th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MediciNova has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MediciNova has only been the subject of 2 research reports in the past 90 days.

  • Read more about MediciNova's stock forecast and price target.
  • Earnings Growth

    Earnings for MediciNova are expected to remain at ($0.24) per share in the coming year.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MediciNova is -5.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MediciNova is -5.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MediciNova has a P/B Ratio of 1.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about MediciNova's valuation and earnings.
  • Percentage of Shares Shorted

    0.35% of the float of MediciNova has been sold short.
  • Short Interest Ratio / Days to Cover

    MediciNova has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediciNova has recently decreased by 2.16%, indicating that investor sentiment is improving.
  • Dividend Yield

    MediciNova does not currently pay a dividend.

  • Dividend Growth

    MediciNova does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.35% of the float of MediciNova has been sold short.
  • Short Interest Ratio / Days to Cover

    MediciNova has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediciNova has recently decreased by 2.16%, indicating that investor sentiment is improving.
    • Insider Buying vs. Insider Selling

      In the past three months, MediciNova insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      13.60% of the stock of MediciNova is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 9.90% of the stock of MediciNova is held by institutions.

    • Read more about MediciNova's insider trading history.
    Receive MNOV Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter.

    MNOV Stock News Headlines

    Trump’s biggest move, misreported
    The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.
    MediciNova says first patient enrolled in EAP trial to evaluate MN-166
    See More Headlines

    MNOV Stock Analysis - Frequently Asked Questions

    MediciNova's stock was trading at $2.10 at the beginning of 2025. Since then, MNOV shares have decreased by 40.5% and is now trading at $1.25.

    MediciNova, Inc. (NASDAQ:MNOV) released its quarterly earnings results on Tuesday, May, 13th. The biopharmaceutical company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.14) by $0.08.

    Shares of MNOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that MediciNova investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), AST SpaceMobile (ASTS), Virgin Galactic (SPCE) and Inuvo (INUV).

    Company Calendar

    Last Earnings
    5/13/2025
    Today
    7/08/2025
    Next Earnings (Estimated)
    8/06/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:MNOV
    CIK
    1226616
    Employees
    10
    Year Founded
    2000

    Price Target and Rating

    High Price Target
    $9.00
    Low Price Target
    $5.00
    Potential Upside/Downside
    +460.0%
    Consensus Rating
    Strong Buy
    Rating Score (0-4)
    3.50
    Research Coverage
    2 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$11.04 million
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $1 million
    Price / Cash Flow
    N/A
    Book Value
    $1.07 per share
    Price / Book
    1.17

    Miscellaneous

    Free Float
    42,376,000
    Market Cap
    $61.31 million
    Optionable
    Optionable
    Beta
    0.40

    Social Links

    A Guide To High-Short-Interest Stocks Cover

    MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

    Get This Free Report

    This page (NASDAQ:MNOV) was last updated on 7/8/2025 by MarketBeat.com Staff
    From Our Partners